Crossmark

Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study

Crossref DOI link: https://doi.org/10.14283/jpad.2024.137

Published Print: 2024-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Papp, Kathryn V.

Maruff, P.

Rentz, D.M.

Donohue, M.C.

Liu, A.

Aisen, P.S.

Sperling, R.A.
License Information

Text and Data Mining valid from 2024-08-01

Text and Data Mining valid from 2024-08-01

Version of Record valid from 2024-07-24
More Information

This article is maintained by: Elsevier

Article Title: Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2024.137

Content Type: article

Copyright: Copyright © 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below